The company’s founder and former CEO, Dr. Uwe Marx, is going to concentrate on the next generation of ground-breaking innovations in his role as Chief Scientific Officer. This is where Uwe Marx will approach the remaining challenges to establish a complex systemic human biology on miniaturised chips. "We are facing technological breakthroughs in the supply of whole blood and the innervation of organ models in combination with a personalized mature immune system on the HUMIMIC® platform. I am delighted to devote all my energy to the translation of these innovations into patient benefit and animal welfare." says the pioneer in the field of multi-organ system development with his 30 years of scientific expertise. Dr. Marx will continue to actively promote the development of a strong international stakeholder community for microphysiological systems.
TissUse is a German biotech company based in Berlin that has developed a unique "Multi-Organ-Chip" technology which makes it possible to conduct preclinical, systemic safety and efficacy testing of substances using a combination of different human tissues. As a result, HUMIMIC products can play a major role in improving, simplifying, and accelerating the development of pharmaceutical, chemical, and cosmetic products.
TissUse GmbH
Oudenarder Str. 16
13347 Berlin
Telefon: +49 (30) 513026400
http://www.tissuse.com